Potassium के लिए Cardiac Arrhythmia

C साक्ष्य की तुलना करें छोटे अध्ययनों से सीमित साक्ष्य उपलब्ध हैं, लेकिन कुछ सकारात्मक संकेत मौजूद हैं।

Hypokalemia is a well-established arrhythmia trigger. Guidelines support maintaining serum K+ >4.0 mEq/L. Research on supplementation benefit in normokalemic patients is unclear.

𝕏 LinkedIn

<\/script>\n

`; }, get iframeSnippet() { const domain = 'heartcited.com'; const params = 'ingredient\u003Dpotassium\u0026condition\u003Darrhythmia'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style

Widget powered by . Free, no account required.

निष्कर्ष

Hypokalemia is a well-established arrhythmia trigger. Guidelines support maintaining serum K+ >4.0 mEq/L. Research on supplementation benefit in normokalemic patients is unclear.

Key Study Findings

Other n=19 1 weeks

Effect of moderate potassium-elevating treatment in long QT syndrome: the TriQarr Potassium Study.

Dose: 50 mg बनाम: baseline Outcome: cardiac repolarisation प्रभाव: None p=0.07

जनसंख्या: lqts with a disease-causing kcnq1 or kcnh2 variant

Cohort Study n=157766 26.0 weeks

Elevated potassium levels in patients with chronic kidney disease: occurrence, risk factors and clinical outcomes-a …

Dose: None बनाम: None Outcome: Incidence of hyperkalemia, mortality प्रभाव: None None

जनसंख्या: Newly diagnosed CKD patients in Denmark

Observational Study n=40

Efficacy and effectiveness of anti-digoxin antibodies in chronic digoxin poisonings from the DORA study (ATOM-1).

Dose: anti-digoxin antibodies (Fab) बनाम: pre-treatment Outcome: serum digoxin and clinical outcomes प्रभाव: Fab bound digoxin; no improved clinical outcomes None

जनसंख्या: Chronic digoxin toxicity patients

Other

Abbott ARCHITECT clinical chemistry and immunoassay systems: digoxin assays are free of interferences from spironolactone, …

Dose: None बनाम: None Outcome: None प्रभाव: None None

जनसंख्या: None

Other

Potassium supplements or potassium-sparing agents.

Dose: None बनाम: None Outcome: mineral status प्रभाव: None None

जनसंख्या: hypertensive patients

Key Statistics

अध्ययन

300

प्रतिभागी

↑

Positive

ग्रेड

Referenced Papers

Effect of moderate potassium-elevating treatment in long QT syndrome: the TriQarr Potassium Study. Other

Open heart 2021 6 उद्धरण

Elevated potassium levels in patients with chronic kidney disease: occurrence, risk factors and clinical outcomes-a Danish population-based cohort study. Other

Nephrology, dialysis, transplantation … 2018 83 उद्धरण

Efficacy and effectiveness of anti-digoxin antibodies in chronic digoxin poisonings from the DORA study (ATOM-1). Observational

Clinical toxicology (Philadelphia, … 2016 25 उद्धरण

Abbott ARCHITECT clinical chemistry and immunoassay systems: digoxin assays are free of interferences from spironolactone, potassium canrenoate, and their common … Other

Therapeutic drug monitoring 2011 17 उद्धरण

Potassium supplements or potassium-sparing agents. Other

Acta pharmacologica et … 1984 3 उद्धरण

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

सामान्य रूप से उपयोग की जाने वाली खुराकें

supplements:: Typically 99 mg/dose (FDA limit per unit)
dashdiettarget:: 4,700 mg/day
whorecommendation:: 3,510 mg/day from food

अधिकतम सीमा: No UL for dietary potassium in healthy individuals; supplemental potassium should be supervised

अनुसंधान में अध्ययन की गई खुराकें

खुराक	अवधि	प्रभाव	N
50 mg	1 weeks	Neutral	19
None	26.0 weeks	Mixed	157766
anti-digoxin antibodies (Fab)	--	Neutral	40
None	--	Positive	--
None	--	Mixed	--

सेवन का सर्वोत्तम समय: With meals to reduce GI irritation; divide supplemental doses throughout the day

Safety & Side Effects

रिपोर्ट किए गए दुष्प्रभाव

⚠ Gastrointestinal irritation (nausea, vomiting, diarrhea)
⚠ Hyperkalemia risk in patients with renal impairment
⚠ Cardiac arrhythmias at excessively high serum levels

ज्ञात अंतःक्रियाएँ

● ACE inhibitors (increased hyperkalemia risk)
● ARBs (increased hyperkalemia risk)
● Potassium-sparing diuretics (increased hyperkalemia risk)
● NSAIDs (may increase potassium retention)

सहनीय अधिकतम सेवन: No UL for dietary potassium in healthy individuals; supplemental potassium should be supervised

कोई भी सप्लीमेंट शुरू करने से पहले हमेशा अपने स्वास्थ्य सेवा प्रदाता से परामर्श करें।

Frequently Asked Questions

Does Potassium help with Cardiac Arrhythmia?

Based on 5 studies with 300 participants, there is limited but promising evidence that Potassium may support Cardiac Arrhythmia management. Our evidence grade is C (Some Evidence).

How much Potassium should I take for Cardiac Arrhythmia?

Studies have used various dosages. A commonly studied range is Typically 99 mg/dose (FDA limit per unit). Always consult your healthcare provider before starting any supplement regimen.

Are there side effects of Potassium?

Reported side effects may include Gastrointestinal irritation (nausea, vomiting, diarrhea), Hyperkalemia risk in patients with renal impairment, Cardiac arrhythmias at excessively high serum levels. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.

How strong is the evidence for Potassium and Cardiac Arrhythmia?

We rate the evidence as Grade C (Some Evidence). This rating is based on 5 peer-reviewed studies with 300 total participants. The overall direction of effect is positive.

इसके लिए अन्य सामग्री Cardiac Arrhythmia

Omega-3 Fatty Acids (EPA/DHA) B Magnesium B Coenzyme Q10 (CoQ10) C

Potassium अन्य स्वास्थ्य स्थितियों के लिए

High Blood Pressure (Hypertension) B

संक्षिप्त निष्कर्ष

Hypokalemia is a well-established arrhythmia trigger. Guidelines support maintaining serum K+ >4.0 mEq/L. Research on supplementation benefit in normokalemic patients is unclear.

Evidence Strength52%

Moderate confidence

अध्ययन विश्लेषण

RCT (0)Meta (0)Other (5)

विकल्पों की तुलना करें

देखें कि इस स्वास्थ्य स्थिति के लिए अन्य सामग्री की तुलना कैसे है।

इसके लिए सभी सामग्री देखें Cardiac Arrhythmia

अधिक जानें

References

[1] Peter Marstrand et al.. Open Heart. 2021. Effect of moderate potassium-elevating treatment in long QT syndrome: the TriQarr Potassium Study. doi:10.1136/openhrt-2021-001670 PubMed
[2] Reimar W Thomsen et al.. Nephrol Dial Transplant. 2018. Elevated potassium levels in patients with chronic kidney disease: occurrence, risk factors and clinical outcomes-a Danish population-based cohort study. doi:10.1093/ndt/gfx312 PubMed
[3] Betty S Chan et al.. Clin Toxicol (Phila). 2016. Efficacy and effectiveness of anti-digoxin antibodies in chronic digoxin poisonings from the DORA study (ATOM-1). doi:10.1080/15563650.2016.1175620 PubMed
[4] Andrea DeFrance et al.. Ther Drug Monit. 2011. Abbott ARCHITECT clinical chemistry and immunoassay systems: digoxin assays are free of interferences from spironolactone, potassium canrenoate, and their common … doi:10.1097/FTD.0b013e3181fd4c30 PubMed
[5] S Persson. Acta Pharmacol Toxicol (Copenh). 1984. Potassium supplements or potassium-sparing agents. doi:10.1111/j.1600-0773.1984.tb03642.x PubMed

FDA अस्वीकरण: इन कथनों का Food and Drug Administration द्वारा मूल्यांकन नहीं किया गया है। इस वेबसाइट पर उत्पादों और जानकारी का उद्देश्य किसी बीमारी का निदान, उपचार, इलाज या रोकथाम नहीं है। प्रस्तुत साक्ष्य ग्रेड प्रकाशित पीयर-रिव्यूड अनुसंधान के हमारे विश्लेषण पर आधारित हैं और चिकित्सा सलाह नहीं हैं। कोई भी सप्लीमेंट शुरू करने से पहले हमेशा अपने स्वास्थ्य सेवा प्रदाता से परामर्श करें।

Potassium के लिए Cardiac Arrhythmia

Embed This Widget

निष्कर्ष

Key Study Findings

Key Statistics

Referenced Papers

Dosage & Usage

सामान्य रूप से उपयोग की जाने वाली खुराकें

अनुसंधान में अध्ययन की गई खुराकें

Safety & Side Effects

रिपोर्ट किए गए दुष्प्रभाव

ज्ञात अंतःक्रियाएँ

Frequently Asked Questions

Related Evidence

इसके लिए अन्य सामग्री Cardiac Arrhythmia

Potassium अन्य स्वास्थ्य स्थितियों के लिए

References